This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident populations ≥50 years of age, living in the community.
In 2021, the Joint United Nations Programme on HIV/AIDS (UNAIDS) updated the HIV targets for 2025 as part of the global strategy to end HIV transmission by 2030.
Migrants are a key population affected by HIV across Europe and Central Asia, accounting for 42% of new HIV diagnoses in the EU/EEA in 2021 and 48% of those diagnosed in 2022.
This report presents HIV/AIDS surveillance data for 2022, a year marked by increased population movements across Europe that have impacted HIV trends, particularly in EU/EEA countries.
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 - 25 November 2023 and includes updates on updates SARS-CoV-2 variant classifications, the increase of pediatric respiratory infections in China, Avian influenza in fur farms, West Nile virus, cholera, and an overview of respiratory virus epidemiology.